Wells Fargo Maintains Equal-Weight on United Therapeutics, Raises Price Target to $486

Benzinga Newsdesk www.benzinga.com Positive 67.5%

Neg 0% Neu 0% Pos 67.5%

Wells Fargo analyst Benjamin Burnett maintains United Therapeutics (NASDAQ:UTHR) with a Equal-Weight and raises the price target from $466 to $486.